| Aspen Pharma Schweiz GmbH - Emla Patch, wirkstoffhaltiges Pflaster | | 52980 | | 01 | | Emla Patch | | wirkstoffhaltiges Pflaster | | N01BB20 | | Kombinationen | | 14.11.1995 | | |
| | Composition | | lidocainum 25 mg, prilocainum 25 mg, macrogol 54 glyceroli hydroxystearas 19 mg, carbomerum 974P, natrii hydroxidum, aqua purificata ad emulsionem pro 1 g, Trägermaterial: cellulosum, lanugo gossypii absorbens, polyamidum, aluminium metallicum, polyethylenum, acrylic adhesive, ad praeparationem pro 10 cm². | | Packungsbestandteile | | wirkstoffhaltiges Pflaster | | | | | | | | Principe actif | Concentr. |
|---|
| Lidocaïne | 25 mg/g | | Prilocaine | 25 mg/g |
| | BAG: Principe actif | Concentr. |
|---|
| Lidocaïne | 25 mg | | Prilocaine | 25 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Aqua Purificata | | | Carbomerum 974P | | | Lyceroli Hydroxystearas | 19 mg/g | | Macrogol | 54 g | | Sodium Hydroxide | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 011 | 2 pansement(s) | 4.13 | 13.75 | B | LS | Non | | 038 | 20 pansement(s) | | 89.95 | B | | Non |
|
|
